New cutting tool may outperform heat therapy for Barrett's esophagus

NCT ID NCT04867590

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This study tests a new device called EndoRotor, which mechanically removes the damaged lining of the esophagus, against the standard heat-based radiofrequency treatment for people with Barrett's esophagus who have precancerous cells (dysplasia). The goal is to see if the new method can completely eliminate the abnormal tissue in a single session, while also allowing for tissue analysis. About 140 adults with Barrett's esophagus measuring 2 to 6 cm will take part, and the main check happens 3 months after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

EndoRotor device (mechanical mucosal resection system)

What this could lead to

If successful, EndoRotor could offer a more effective, one-session treatment for Barrett's esophagus, potentially reducing the risk of hidden precancerous glands and lowering costs.

What could go wrong

This is a relatively early comparison study with 140 participants. The new technique may not prove superior, and carries risks like perforation or bleeding. Long-term outcomes are not yet known.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BARRETT ESOPHAGUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Barrett adenocarcinoma Barrett esophagus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cochin Hospital

    ACTIVE_NOT_RECRUITING

    Paris, France

  • Edouard Herriot Hospital

    RECRUITING

    Lyon, France

    Contact

  • Georges Pompidou European Hospital

    WITHDRAWN

    Paris, France

  • UNiversity Hospital of Toulouse

    RECRUITING

    Toulouse, France

    Contact

  • University Hospital of Besançon

    RECRUITING

    Besançon, France

    Contact

  • University Hospital of Bordeaux

    RECRUITING

    Pessac, France

    Contact

  • University Hospital of Brest

    NOT_YET_RECRUITING

    Brest, France

    Contact

  • University Hospital of Dijon

    RECRUITING

    Dijon, France

    Contact

  • University Hospital of Lille

    RECRUITING

    Lille, France

    Contact

  • University Hospital of Limoges

    RECRUITING

    Limoges, France

    Contact

  • University Hospital of Montpellier

    RECRUITING

    Montpellier, France

    Contact

  • University Hospital of Nancy

    RECRUITING

    Nancy, France

    Contact

  • University Hospital of Nantes

    RECRUITING

    Nantes, France

    Contact

  • University Hospital of Nice

    NOT_YET_RECRUITING

    Nice, France

    Contact

  • University Hospital of Poitiers

    NOT_YET_RECRUITING

    Poitiers, France

    Contact

  • University Hospital of Rennes

    NOT_YET_RECRUITING

    Rennes, France

    Contact

  • University Hospital of Tours

    RECRUITING

    Chambray-lès-Tours, France

    Contact